Clinical Trial Update: Functional Magnetic Resonance Imaging (fMRI) Investigation of Nicotine Withdrawal Symptoms [Phase 4]

View source ↗

Summary

A Phase 4 trial sponsored by GlaxoSmithKline used functional MRI to investigate nicotine withdrawal symptoms in smokers; the study has completed and results wer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nicotine Dependence
• Tobacco Use Disorder

Snippet

Sponsor: GlaxoSmithKline | Conditions: Smoking | Phase 4 | Status: COMPLETED | Results posted: 2010-04-06